Aslan Pharmaceuticals Ltd ADR ASLN
$0.60
-0.10
(-14.27%)
Valuation
- Market cap
- 1,226,000
- Revenue TTM
- $12,000,000
- Net income TTM
- $-44,220,000
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- —
- Debt to equity
- —
Trading
- Volume
- 806,300
- Avg volume
- 130,501
- Day's range
- $0.60 – $0.70
- Shares out
- 2,044,000
- Stochastic %K
- 6%
- Beta
- 1.40
- Analysts
- Strong Buy
- Price target
- $76.00
Latest news
No headlines yet.
